Berita/Reuters/Curevac and GSK agree to resolve patent dispute litigation with Pfizer and BioNTechCurevac and GSK agree to resolve patent dispute litigation with Pfizer and BioNTechRefinitivBacaan kurang dari 1 minitCVACGSKPFEBNTXCurevac CVAC said on Thursday that the company and GSK GSK have entered an agreement to resolve patent dispute with Pfizer PFE and BioNTech BNTX over mRNA-based COVID-19 vaccines. EropahReutersSaham ASSaham JermanSaham UK© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.htmlPaparkan lebih lanjutLog masuk atau cipta satu akaun percuma selamanya untuk membaca berita iniJom pergi
